id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-N-0191-0003,FDA,FDA-2004-N-0191,Definition of Primary Mode of Action of a Combination Product,Rule,Final Rule,2005-08-25T04:00:00Z,2005,8,,,2025-04-22T11:55:50Z,05-16527,0,0,09000064804709ac